comparemela.com

Latest Breaking News On - Nyse syk - Page 1 : comparemela.com

Maryland State Retirement & Pension System Boosts Position in Stryker Co (NYSE:SYK)

Maryland State Retirement & Pension System raised its stake in Stryker Co. (NYSE:SYK – Free Report) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 27,656 shares of the medical technology company’s stock after purchasing an additional 294 shares during the […]

Stryker Co (NYSE:SYK) Position Lessened by Clifford Swan Investment Counsel LLC

Clifford Swan Investment Counsel LLC reduced its stake in shares of Stryker Co. (NYSE:SYK – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,203 shares of the medical technology company’s stock after selling 1,060 shares […]

Stryker Co (NYSE:SYK) Shares Sold by Summit Trail Advisors LLC

Summit Trail Advisors LLC trimmed its position in shares of Stryker Co. (NYSE:SYK – Free Report) by 6.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,532 shares of the medical technology company’s stock after selling 294 shares during the quarter. Summit Trail Advisors LLC’s holdings […]

Stryker (NYSE:SYK) Price Target Raised to $351 00

Stryker (NYSE:SYK – Free Report) had its price target upped by UBS Group from $339.00 to $351.00 in a research note published on Wednesday morning, Benzinga reports. They currently have a neutral rating on the medical technology company’s stock. A number of other analysts have also commented on the company. TD Cowen lifted their price […]

Wells Fargo & Company Boosts Stryker (NYSE:SYK) Price Target to $381 00

Stryker (NYSE:SYK – Free Report) had its target price lifted by Wells Fargo & Company from $364.00 to $381.00 in a research report sent to investors on Wednesday morning, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the medical technology company’s stock. A number of other brokerages have also weighed in […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.